Search research articles
Contact Us
Filters
Showing results (1-10 of 44) with videos related to
Page
of 5
Sort By:
American Journal of Respiratory and Critical Care Medicine
|
August 16, 2014
Emphysema genetics. Location, location, location!
Sreekumar G Pillai
JAMA Cardiology
|
August 10, 2018
Randomized Trial Needed to Confirm Whether Dalcetrapib Improves Outcomes for Specific ADCY9 Genotype-Reply
Steven E Nissen, Sreekumar G Pillai
Human Molecular Genetics
|
March 13, 2009
Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary disease
Guohua Zhu, , Amund Gulsvik, et al.
Pharmacogenetics and Genomics
|
November 8, 2005
Pharmacogenetics and obesity: common gene variants influence weight loss response of the norepinephrine/dopamine transporter inhibitor GW320659 in obese subjects
Colin F Spraggs, Sreekumar G Pillai, David Dow, et al.
BMC Medical Genomics
|
January 14, 2015
Identifying a gene expression signature of frequent COPD exacerbations in peripheral blood using network methods
Jarrett D Morrow, Weiliang Qiu, Divya Chhabra, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 21, 2007
The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations
Guohua Zhu, Liling Warren, Jennifer Aponte, et al.
European Journal of Human Genetics : EJHG
|
April 3, 2008
Interleukin 18 receptor 1 gene polymorphisms are associated with asthma
Guohua Zhu, Moira K B Whyte, Jorgen Vestbo, et al.
Hormone Research in Paediatrics
|
April 11, 2019
Genetic Polymorphisms Associated with Idiopathic Short Stature and First-Year Response to Growth Hormone Treatment
Charmian A Quigley, Ying Grace Li, Milton R Brown, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 27, 2010
Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease
Sreekumar G Pillai, Xiangyang Kong, Lisa D Edwards, et al.
Diabetes, Obesity & Metabolism
|
April 4, 2017
Treatment with LY2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes
Cristina B Guzman, Xiaotian M Zhang, Rong Liu, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 44) with videos related to
Sort By:
Page
of 5
American Journal of Respiratory and Critical Care Medicine
|
August 16, 2014
Emphysema genetics. Location, location, location!
Sreekumar G Pillai
JAMA Cardiology
|
August 10, 2018
Randomized Trial Needed to Confirm Whether Dalcetrapib Improves Outcomes for Specific ADCY9 Genotype-Reply
Steven E Nissen, Sreekumar G Pillai
Human Molecular Genetics
|
March 13, 2009
Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary disease
Guohua Zhu, , Amund Gulsvik, et al.
Pharmacogenetics and Genomics
|
November 8, 2005
Pharmacogenetics and obesity: common gene variants influence weight loss response of the norepinephrine/dopamine transporter inhibitor GW320659 in obese subjects
Colin F Spraggs, Sreekumar G Pillai, David Dow, et al.
BMC Medical Genomics
|
January 14, 2015
Identifying a gene expression signature of frequent COPD exacerbations in peripheral blood using network methods
Jarrett D Morrow, Weiliang Qiu, Divya Chhabra, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 21, 2007
The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations
Guohua Zhu, Liling Warren, Jennifer Aponte, et al.
European Journal of Human Genetics : EJHG
|
April 3, 2008
Interleukin 18 receptor 1 gene polymorphisms are associated with asthma
Guohua Zhu, Moira K B Whyte, Jorgen Vestbo, et al.
Hormone Research in Paediatrics
|
April 11, 2019
Genetic Polymorphisms Associated with Idiopathic Short Stature and First-Year Response to Growth Hormone Treatment
Charmian A Quigley, Ying Grace Li, Milton R Brown, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 27, 2010
Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease
Sreekumar G Pillai, Xiangyang Kong, Lisa D Edwards, et al.
Diabetes, Obesity & Metabolism
|
April 4, 2017
Treatment with LY2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes
Cristina B Guzman, Xiaotian M Zhang, Rong Liu, et al.
Page
of 5